This event is archived. Final snapshot from when the story concluded. View on Dashboard
Business class action

Zynex faces class action lawsuit

Analysis based on 13 articles · First reported Mar 24, 2025 · Last updated Apr 13, 2025

Sentiment
-40
Attention
2
Articles
13
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The class action lawsuit against Zynex could lead to significant financial penalties and reputational damage for Zynex, potentially impacting its stock price negatively. Investors who purchased Zynex securities during the Class Period may be entitled to compensation.

Medical Devices Legal Services

Rosen Law Firm has filed a class action lawsuit against Zynex, alleging that the company inflated its revenue by shipping products, including electrodes, in excess of need and filing false claims. This practice reportedly drew scrutiny from insurers, including United States — Tricare, making it likely that Zynex would face adverse consequences such as removal from insurer networks and penalties from the federal government. The lawsuit covers purchasers of Zynex securities between March 13, 2023, and March 11, 2025. Investors are encouraged to join the class action by the May 19, 2025, lead plaintiff deadline.

100 Rosen Law Firm filed class action lawsuit Zynex
90 Zynex shipped products in excess
90 Zynex filed false claims United States — Tricare
stock
Zynex is facing a class action lawsuit for allegedly inflating revenue by shipping products in excess of need and filing false claims, which could lead to adverse consequences like removal from insurer networks and government penalties.
Importance 100.0 Sentiment -70.0
govactor
United States — Tricare is mentioned as one of the insurers whose scrutiny was drawn by Zynex's practice of filing false claims.
Importance 30.0 Sentiment 0.0
priv
Importance 0.0 Sentiment 0.0
per
Importance 0.0 Sentiment 0.0
per
Importance 0.0 Sentiment 0.0
Zynex investigated provider United States — Tricare Zynex is a medical device provider that bills the US government's Tricare program. The relationship is currently adversa
Lawrence Rosen founding partner Philip Kim Lawrence Rosen is a founding partner of the Rosen Law Firm, where he directs attorneys including Philip Kim. Together, t
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.